The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable to military hardening and integration with communication capabilities to support the medical [Read more]
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate high payoff potential to Counter-WMD (C-WMD) threats, including chemical, biological, radiological, nuclear [Read more]
In a new article published in The Lancet, experts review the current field of Ebola vaccine candidates and clinical trials and highlight key gaps in knowledge that need to be addressed by [Read more]
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is the Department of Defense’s (DoD) lead laboratory for medical biological defense research. USAMRIID has awarded a sole source contract to Life [Read more]
Health officials in Democratic Republic of Congo have reported 21 patients showing signs of hemorrhagic fever and 17 deaths in the affected area before an Ebola outbreak was confirmed today. Ground teams [Read more]
See what we’re reading this week at Global Biodefense on topics including regulation of genetically engineered livestock, chemical weapons investigators in Douma, and the latest news on rapid diagnostics. POLICY + INITIATIVES GAO asks [Read more]
See what we’re reading this week at Global Biodefense on topics including transnational biological threats, modernizing epidemiology, smallpox vaccine MVA, and drug-resistant typhoid outbreaks. POLICY + INITIATIVES NIAID research addressing biodefense and emerging and [Read more]
See what we’re reading this week at Global Biodefense on topics including early warning systems for WMDs, experimental Ebola vaccines, and the new congressional biodefense caucus. BIOPREPAREDNESS An early warning system for WMDs The [Read more]
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic [Read more]
The Defense Advanced Research Projects Agency (DARPA) launched the Pandemic Prevention Platform (P3) program in 2017, with the eventual goal of halting the spread of any infectious disease outbreak before it can escalate into a pandemic. [Read more]
© 2018 STEMAR MEDIA